Genetic variation in CSF2 (5q31.1) is associated with longitudinal susceptibility to pediatric malaria, severe malarial anemia, and all-cause mortality in a high-burden malaria and HIV region of Kenya

Abstract Plasmodium falciparum infections remain among the leading causes of morbidity and mortality in holoendemic transmission areas. Located within region 5q31.1, the colony-stimulating factor 2 gene (CSF2) encodes granulocyte–macrophage colony-stimulating factor (GM-CSF), a hematopoietic growth...

Full description

Bibliographic Details
Main Authors: Lily E. Kisia, Qiuying Cheng, Evans Raballah, Elly O. Munde, Benjamin H. McMahon, Nick W. Hengartner, John M. Ong’echa, Kiprotich Chelimo, Christophe G. Lambert, Collins Ouma, Prakasha Kempaiah, Douglas J. Perkins, Kristan A. Schneider, Samuel B. Anyona
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Tropical Medicine and Health
Subjects:
Online Access:https://doi.org/10.1186/s41182-022-00432-5
_version_ 1828195170147893248
author Lily E. Kisia
Qiuying Cheng
Evans Raballah
Elly O. Munde
Benjamin H. McMahon
Nick W. Hengartner
John M. Ong’echa
Kiprotich Chelimo
Christophe G. Lambert
Collins Ouma
Prakasha Kempaiah
Douglas J. Perkins
Kristan A. Schneider
Samuel B. Anyona
author_facet Lily E. Kisia
Qiuying Cheng
Evans Raballah
Elly O. Munde
Benjamin H. McMahon
Nick W. Hengartner
John M. Ong’echa
Kiprotich Chelimo
Christophe G. Lambert
Collins Ouma
Prakasha Kempaiah
Douglas J. Perkins
Kristan A. Schneider
Samuel B. Anyona
author_sort Lily E. Kisia
collection DOAJ
description Abstract Plasmodium falciparum infections remain among the leading causes of morbidity and mortality in holoendemic transmission areas. Located within region 5q31.1, the colony-stimulating factor 2 gene (CSF2) encodes granulocyte–macrophage colony-stimulating factor (GM-CSF), a hematopoietic growth factor that mediates host immune responses. Since the effect of CSF2 variation on malaria pathogenesis remains unreported, we investigated the impact of two genetic variants in the 5q31.1 gene region flanking CSF2:g-7032 G > A (rs168681:G > A) and CSF2:g.64544T > C (rs246835:T > C) on the rate and timing of malaria and severe malarial anemia (SMA, Hb < 5.0 g/dL) episodes over 36 months of follow-up. Children (n = 1654, aged 2–70 months) were recruited from a holoendemic P. falciparum transmission area of western Kenya. Decreased incidence rate ratio (IRR) for malaria was conferred by inheritance of the CSF2:g.64544 TC genotype (P = 0.0277) and CSF2 AC/GC diplotype (P = 0.0015). Increased IRR for malaria was observed in carriers of the CSF2 AT/GC diplotype (P = 0.0237), while the inheritance of the CSF2 AT haplotype increased the IRR for SMA (P = 0.0166). A model estimating the longitudinal risk of malaria showed decreased hazard rates among CSF2 AC haplotype carriers (P = 0.0045). Investigation of all-cause mortality revealed that inheritance of the GA genotype at CSF2:g-7032 increased the risk of mortality (P = 0.0315). Higher risk of SMA and all-cause mortality were observed in younger children (P < 0.0001 and P = 0.0015), HIV-1(+) individuals (P < 0.0001 and P < 0.0001), and carriers of HbSS (P = 0.0342 and P = 0.0019). Results from this holoendemic P. falciparum area show that variation in gene region 5q31.1 influences susceptibility to malaria, SMA, and mortality, as does age, HIV-1 status, and inheritance of HbSS.
first_indexed 2024-04-12T09:39:01Z
format Article
id doaj.art-9181a3a765424ab5950663800c7efad4
institution Directory Open Access Journal
issn 1349-4147
language English
last_indexed 2024-04-12T09:39:01Z
publishDate 2022-06-01
publisher BMC
record_format Article
series Tropical Medicine and Health
spelling doaj.art-9181a3a765424ab5950663800c7efad42022-12-22T03:38:09ZengBMCTropical Medicine and Health1349-41472022-06-0150111510.1186/s41182-022-00432-5Genetic variation in CSF2 (5q31.1) is associated with longitudinal susceptibility to pediatric malaria, severe malarial anemia, and all-cause mortality in a high-burden malaria and HIV region of KenyaLily E. Kisia0Qiuying Cheng1Evans Raballah2Elly O. Munde3Benjamin H. McMahon4Nick W. Hengartner5John M. Ong’echa6Kiprotich Chelimo7Christophe G. Lambert8Collins Ouma9Prakasha Kempaiah10Douglas J. Perkins11Kristan A. Schneider12Samuel B. Anyona13Department of Biomedical Sciences and Technology, School of Public Health and Community Development, Maseno UniversityCenter for Global Health, University of New MexicoUniversity of New Mexico-Kenya Global Health ProgramsUniversity of New Mexico-Kenya Global Health ProgramsTheoretical Biology and Biophysics Group, Theoretical Division, Los Alamos National LaboratoryTheoretical Biology and Biophysics Group, Theoretical Division, Los Alamos National LaboratoryCentre for Global Health Research, Kenya Medical Research InstituteDepartment of Biomedical Sciences and Technology, School of Public Health and Community Development, Maseno UniversityCenter for Global Health, University of New MexicoDepartment of Biomedical Sciences and Technology, School of Public Health and Community Development, Maseno UniversityDepartment of Medicine, Loyola University Medical CenterUniversity of New Mexico-Kenya Global Health ProgramsDepartment Applied Computer and Bio-Sciences, University of Applied Sciences MittweidaUniversity of New Mexico-Kenya Global Health ProgramsAbstract Plasmodium falciparum infections remain among the leading causes of morbidity and mortality in holoendemic transmission areas. Located within region 5q31.1, the colony-stimulating factor 2 gene (CSF2) encodes granulocyte–macrophage colony-stimulating factor (GM-CSF), a hematopoietic growth factor that mediates host immune responses. Since the effect of CSF2 variation on malaria pathogenesis remains unreported, we investigated the impact of two genetic variants in the 5q31.1 gene region flanking CSF2:g-7032 G > A (rs168681:G > A) and CSF2:g.64544T > C (rs246835:T > C) on the rate and timing of malaria and severe malarial anemia (SMA, Hb < 5.0 g/dL) episodes over 36 months of follow-up. Children (n = 1654, aged 2–70 months) were recruited from a holoendemic P. falciparum transmission area of western Kenya. Decreased incidence rate ratio (IRR) for malaria was conferred by inheritance of the CSF2:g.64544 TC genotype (P = 0.0277) and CSF2 AC/GC diplotype (P = 0.0015). Increased IRR for malaria was observed in carriers of the CSF2 AT/GC diplotype (P = 0.0237), while the inheritance of the CSF2 AT haplotype increased the IRR for SMA (P = 0.0166). A model estimating the longitudinal risk of malaria showed decreased hazard rates among CSF2 AC haplotype carriers (P = 0.0045). Investigation of all-cause mortality revealed that inheritance of the GA genotype at CSF2:g-7032 increased the risk of mortality (P = 0.0315). Higher risk of SMA and all-cause mortality were observed in younger children (P < 0.0001 and P = 0.0015), HIV-1(+) individuals (P < 0.0001 and P < 0.0001), and carriers of HbSS (P = 0.0342 and P = 0.0019). Results from this holoendemic P. falciparum area show that variation in gene region 5q31.1 influences susceptibility to malaria, SMA, and mortality, as does age, HIV-1 status, and inheritance of HbSS.https://doi.org/10.1186/s41182-022-00432-5P. falciparumCSF2GM-CSFMalariaGenotypesHaplotypes
spellingShingle Lily E. Kisia
Qiuying Cheng
Evans Raballah
Elly O. Munde
Benjamin H. McMahon
Nick W. Hengartner
John M. Ong’echa
Kiprotich Chelimo
Christophe G. Lambert
Collins Ouma
Prakasha Kempaiah
Douglas J. Perkins
Kristan A. Schneider
Samuel B. Anyona
Genetic variation in CSF2 (5q31.1) is associated with longitudinal susceptibility to pediatric malaria, severe malarial anemia, and all-cause mortality in a high-burden malaria and HIV region of Kenya
Tropical Medicine and Health
P. falciparum
CSF2
GM-CSF
Malaria
Genotypes
Haplotypes
title Genetic variation in CSF2 (5q31.1) is associated with longitudinal susceptibility to pediatric malaria, severe malarial anemia, and all-cause mortality in a high-burden malaria and HIV region of Kenya
title_full Genetic variation in CSF2 (5q31.1) is associated with longitudinal susceptibility to pediatric malaria, severe malarial anemia, and all-cause mortality in a high-burden malaria and HIV region of Kenya
title_fullStr Genetic variation in CSF2 (5q31.1) is associated with longitudinal susceptibility to pediatric malaria, severe malarial anemia, and all-cause mortality in a high-burden malaria and HIV region of Kenya
title_full_unstemmed Genetic variation in CSF2 (5q31.1) is associated with longitudinal susceptibility to pediatric malaria, severe malarial anemia, and all-cause mortality in a high-burden malaria and HIV region of Kenya
title_short Genetic variation in CSF2 (5q31.1) is associated with longitudinal susceptibility to pediatric malaria, severe malarial anemia, and all-cause mortality in a high-burden malaria and HIV region of Kenya
title_sort genetic variation in csf2 5q31 1 is associated with longitudinal susceptibility to pediatric malaria severe malarial anemia and all cause mortality in a high burden malaria and hiv region of kenya
topic P. falciparum
CSF2
GM-CSF
Malaria
Genotypes
Haplotypes
url https://doi.org/10.1186/s41182-022-00432-5
work_keys_str_mv AT lilyekisia geneticvariationincsf25q311isassociatedwithlongitudinalsusceptibilitytopediatricmalariaseveremalarialanemiaandallcausemortalityinahighburdenmalariaandhivregionofkenya
AT qiuyingcheng geneticvariationincsf25q311isassociatedwithlongitudinalsusceptibilitytopediatricmalariaseveremalarialanemiaandallcausemortalityinahighburdenmalariaandhivregionofkenya
AT evansraballah geneticvariationincsf25q311isassociatedwithlongitudinalsusceptibilitytopediatricmalariaseveremalarialanemiaandallcausemortalityinahighburdenmalariaandhivregionofkenya
AT ellyomunde geneticvariationincsf25q311isassociatedwithlongitudinalsusceptibilitytopediatricmalariaseveremalarialanemiaandallcausemortalityinahighburdenmalariaandhivregionofkenya
AT benjaminhmcmahon geneticvariationincsf25q311isassociatedwithlongitudinalsusceptibilitytopediatricmalariaseveremalarialanemiaandallcausemortalityinahighburdenmalariaandhivregionofkenya
AT nickwhengartner geneticvariationincsf25q311isassociatedwithlongitudinalsusceptibilitytopediatricmalariaseveremalarialanemiaandallcausemortalityinahighburdenmalariaandhivregionofkenya
AT johnmongecha geneticvariationincsf25q311isassociatedwithlongitudinalsusceptibilitytopediatricmalariaseveremalarialanemiaandallcausemortalityinahighburdenmalariaandhivregionofkenya
AT kiprotichchelimo geneticvariationincsf25q311isassociatedwithlongitudinalsusceptibilitytopediatricmalariaseveremalarialanemiaandallcausemortalityinahighburdenmalariaandhivregionofkenya
AT christopheglambert geneticvariationincsf25q311isassociatedwithlongitudinalsusceptibilitytopediatricmalariaseveremalarialanemiaandallcausemortalityinahighburdenmalariaandhivregionofkenya
AT collinsouma geneticvariationincsf25q311isassociatedwithlongitudinalsusceptibilitytopediatricmalariaseveremalarialanemiaandallcausemortalityinahighburdenmalariaandhivregionofkenya
AT prakashakempaiah geneticvariationincsf25q311isassociatedwithlongitudinalsusceptibilitytopediatricmalariaseveremalarialanemiaandallcausemortalityinahighburdenmalariaandhivregionofkenya
AT douglasjperkins geneticvariationincsf25q311isassociatedwithlongitudinalsusceptibilitytopediatricmalariaseveremalarialanemiaandallcausemortalityinahighburdenmalariaandhivregionofkenya
AT kristanaschneider geneticvariationincsf25q311isassociatedwithlongitudinalsusceptibilitytopediatricmalariaseveremalarialanemiaandallcausemortalityinahighburdenmalariaandhivregionofkenya
AT samuelbanyona geneticvariationincsf25q311isassociatedwithlongitudinalsusceptibilitytopediatricmalariaseveremalarialanemiaandallcausemortalityinahighburdenmalariaandhivregionofkenya